Juan Fernandez-Ruiz - Publications

Affiliations: 
UNAM, Ciudad de México, Ciudad de México, Mexico 
Area:
Cognitive Neuroscience
Website:
http://neurocog.blogspot.com/

69/324 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lopez-Titla MM, Chirino A, Cruz Solis SV, Hernandez-Castillo CR, Diaz R, Márquez-Quiroz LDC, Magaña JJ, Beltrán-Parrazal L, Fernandez-Ruiz J. Cognitive Decline and White Matter Integrity Degradation in Myotonic Dystrophy Type I. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 32936994 DOI: 10.1111/jon.12786  0.6
2020 Hernandez-Castillo CR, Rasmussen A, Fernandez-Ruiz J. Cerebellar and thalamic degeneration in spinocerebellar ataxia type 10. The devil is in the details. Parkinsonism & Related Disorders. PMID 32205044 DOI: 10.1016/j.parkreldis.2020.03.006  0.6
2020 Rodríguez-Labrada R, Martins AC, Magaña JJ, Vazquez-Mojena Y, Medrano-Montero J, Fernandez-Ruíz J, Cisneros B, Teive H, McFarland KN, Saraiva-Pereira ML, Cerecedo-Zapata CM, Gomez CM, Ashizawa T, Velázquez-Pérez L, Jardim LB, et al. Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean. Cerebellum (London, England). PMID 32086717 DOI: 10.1007/s12311-020-01109-7  0.32
2019 Gómez-Moya R, Diaz R, Vaca-Palomares I, Fernandez-Ruiz J. Procedural and Strategic Visuomotor Learning Deficits in Children with Developmental Coordination Disorder. Research Quarterly For Exercise and Sport. 1-8. PMID 31774375 DOI: 10.1080/02701367.2019.1675852  0.6
2019 Ramirez-Garcia G, Galvez V, Diaz R, Bayliss L, Fernandez-Ruiz J, Campos-Romo A. Longitudinal atrophy characterization of cortical and subcortical gray matter in Huntington's disease patients. The European Journal of Neuroscience. PMID 31705594 DOI: 10.1111/ejn.14617  0.8
2019 Vaca-Palomares I, Brien DC, Coe BC, Ochoa-Morales A, Martínez-Ruano L, Munoz DP, Fernandez-Ruiz J. Implicit learning impairment identified via predictive saccades in Huntington's disease correlates with extended cortico-striatal atrophy. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 121: 89-103. PMID 31550618 DOI: 10.1016/j.cortex.2019.06.013  0.6
2019 Hernandez-Castillo CR, Diaz R, Vaca-Palomares I, Torres DL, Chirino A, Campos-Romo A, Ochoa A, Rasmussen A, Fernandez-Ruiz J. Extensive cerebellar and thalamic degeneration in spinocerebellar ataxia type 10. Parkinsonism & Related Disorders. PMID 31445906 DOI: 10.1016/j.parkreldis.2019.08.011  0.8
2018 Hernandez-Castillo CR, King M, Diedrichsen J, Fernandez-Ruiz J. Unique degeneration signatures in the cerebellar cortex for spinocerebellar ataxias 2, 3, and 7. Neuroimage. Clinical. 20: 931-938. PMID 30308379 DOI: 10.1016/j.nicl.2018.09.026  0.6
2018 Chirino A, Hernandez-Castillo CR, Galvez V, Contreras A, Diaz R, Beltran-Parrazal L, Fernandez-Ruiz J. Motor and cognitive impairments in spinocerebellar ataxia type 7 and its correlations with cortical volumes. The European Journal of Neuroscience. PMID 30255962 DOI: 10.1111/ejn.14148  1
2018 Galvez V, Ramírez-García G, Hernandez-Castillo CR, Bayliss L, Díaz R, Lopez-Titla MM, Campos-Romo A, Fernandez-Ruiz J. Extrastriatal degeneration correlates with deficits in the motor domain subscales of the UHDRS. Journal of the Neurological Sciences. 385: 22-29. PMID 29406908 DOI: 10.1016/j.jns.2017.11.040  0.8
2017 Ronzon-Gonzalez E, Hernandez-Castillo CR, Pasaye EH, Vaca-Palomares I, Fernandez-Ruiz J. Neuroanatomical substrates involved in unrelated false facial recognition. Social Neuroscience. PMID 29137530 DOI: 10.1080/17470919.2017.1405071  0.6
2017 Hernandez-Castillo CR, Nashed JY, Fernandez-Ruiz J, Wang J, Gallivan J, Cook DJ. Increased functional connectivity after stroke correlates with behavioral scores in non-human primate model. Scientific Reports. 7: 6701. PMID 28751636 DOI: 10.1038/s41598-017-07175-y  0.6
2017 Vaca-Palomares I, Coe BC, Brien DC, Munoz DP, Fernandez-Ruiz J. Voluntary saccade inhibition deficits correlate with extended white-matter cortico-basal atrophy in Huntington's disease. Neuroimage. Clinical. 15: 502-512. PMID 28649493 DOI: 10.1016/j.nicl.2017.06.007  0.6
2017 Reyes-Aguilar A, Fernandez-Ruiz J, Pasaye EH, Barrios FA. Executive Mechanisms for Thinking about Negative Situations in Both Cooperative and Non-Cooperative Contexts. Frontiers in Human Neuroscience. 11: 275. PMID 28596727 DOI: 10.3389/fnhum.2017.00275  0.6
2017 Hernandez-Castillo CR, Diaz R, Campos-Romo A, Fernandez-Ruiz J. Neural correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph disease. Cerebellum & Ataxias. 4: 7. PMID 28593048 DOI: 10.1186/s40673-017-0065-7  0.8
2017 Galvez V, Fernandez-Ruiz J, Bayliss L, Ochoa-Morales A, Hernandez-Castillo CR, Díaz R, Campos-Romo A. Early Huntington's Disease: Impulse Control Deficits but Correct Judgment Regarding Risky Situations. Journal of Huntington's Disease. PMID 28339399 DOI: 10.3233/JHD-160223  0.8
2016 Hernandez-Castillo CR, Vaca-Palomares I, Barrios F, Martinez L, Boll MC, Fernandez-Ruiz J. Ataxia Severity Correlates with White Matter Degeneration in Spinocerebellar Ataxia Type 7. Ajnr. American Journal of Neuroradiology. PMID 27516240 DOI: 10.3174/ajnr.A4903  0.6
2016 Hernandez-Castillo CR, Vaca-Palomares I, Galvez V, Campos-Romo A, Diaz R, Fernandez-Ruiz J. Cognitive Deficits Correlate with White Matter Deterioration in Spinocerebellar Ataxia Type 2. Journal of the International Neuropsychological Society : Jins. 1-6. PMID 26888086 DOI: 10.1017/S1355617716000084  1
2016 Gómez-Moya R, Díaz R, Fernandez-Ruiz J. Different visuomotor processes maturation rates in children support dual visuomotor learning systems. Human Movement Science. 46: 221-228. PMID 26802974 DOI: 10.1016/j.humov.2016.01.011  1
2016 Reginold W, Luedke AC, Itorralba J, Fernandez-Ruiz J, Islam O, Garcia A. Altered Superficial White Matter on Tractography MRI in Alzheimer's Disease Dementia and Geriatric Cognitive Disorders Extra. 233-241. DOI: 10.1159/000446770  1
2015 Hernandez-Castillo CR, Aguilar-Castañeda E, Iglesias M, Fernandez-Ruiz J. Motor and sensory cortical reorganization after bilateral forearm transplantation: Four-year follow up fMRI case study. Magnetic Resonance Imaging. PMID 26708028 DOI: 10.1016/j.mri.2015.12.025  1
2015 Reginold W, Itorralba J, Tam A, Luedke AC, Fernandez-Ruiz J, Reginold J, Islam O, Garcia A. Correlating quantitative tractography at 3T MRI and cognitive tests in healthy older adults. Brain Imaging and Behavior. PMID 26650629 DOI: 10.1007/s11682-015-9495-0  1
2015 Uresti-Cabrera LA, Diaz R, Vaca-Palomares I, Fernandez-Ruiz J. The Effect of Spatial Working Memory Deterioration on Strategic Visuomotor Learning across Aging. Behavioural Neurology. 2015: 512617. PMID 26290623 DOI: 10.1155/2015/512617  0.6
2015 Hernandez-Castillo CR, Galvez V, Mercadillo R, Diaz R, Campos-Romo A, Fernandez-Ruiz J. Extensive White Matter Alterations and Its Correlations with Ataxia Severity in SCA 2 Patients. Plos One. 10: e0135449. PMID 26263162 DOI: 10.1371/journal.pone.0135449  1
2015 Hernandez-Castillo CR, Galvez V, Mercadillo RE, Díaz R, Yescas P, Martinez L, Ochoa A, Velazquez-Perez L, Fernandez-Ruiz J. Functional connectivity changes related to cognitive and motor performance in spinocerebellar ataxia type 2. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1391-9. PMID 26256273 DOI: 10.1002/mds.26320  0.6
2015 Mercadillo RE, Galvez V, Díaz R, Paredes L, Velázquez-Moctezuma J, Hernandez-Castillo CR, Fernandez-Ruiz J. Social and Cultural Elements Associated with Neurocognitive Dysfunctions in Spinocerebellar Ataxia Type 2 Patients. Frontiers in Psychiatry. 6: 90. PMID 26113822 DOI: 10.3389/fpsyt.2015.00090  0.6
2015 Alfonso Uresti-Cabrera L, Vaca-Palomares I, Diaz R, Beltran-Parrazal L, Fernandez-Ruiz J. Effects of aging on strategic-based visuomotor learning. Brain Research. PMID 26014620 DOI: 10.1016/j.brainres.2015.05.022  1
2015 Hernandez-Castillo CR, Galvez V, Diaz R, Fernandez-Ruiz J. Specific cerebellar and cortical degeneration correlates with ataxia severity in spinocerebellar ataxia type 7. Brain Imaging and Behavior. PMID 25917872 DOI: 10.1007/s11682-015-9389-1  1
2015 Vaca-Palomares I, Díaz R, Rodríguez-Labrada R, Medrano-Montero J, Aguilera-Rodríguez R, Vázquez-Mojena Y, Fernandez-Ruiz J, Velázquez-Pérez L. Strategy use, planning, and rule acquisition deficits in spinocerebellar ataxia type 2 patients. Journal of the International Neuropsychological Society : Jins. 21: 214-20. PMID 25796959 DOI: 10.1017/S1355617715000132  1
2015 Morgado-Valle C, Fernandez-Ruiz J, Lopez-Meraz L, Beltran-Parrazal L. Substitution of extracellular Ca2+ by Sr2+ prolongs inspiratory burst in pre-Bötzinger complex inspiratory neurons. Journal of Neurophysiology. 113: 1175-83. PMID 25429120 DOI: 10.1152/jn.00705.2014  1
2015 Mercadillo RE, Alcauter S, Fernández-Ruiz J, Barrios FA. Police culture influences the brain function underlying compassion: a gender study. Social Neuroscience. 10: 135-52. PMID 25372925 DOI: 10.1080/17470919.2014.977402  0.6
2015 Mercadillo RE, Galvez V, Díaz R, Paredes L, Velázquez-Moctezuma J, Hernandez-Castillo CR, Fernandez-Ruiz J. Social and cultural elements associated with neurocognitive dysfunctions in Spinocerebellar Ataxia Type 2 patients Frontiers in Psychiatry. 6. DOI: 10.3389/fpsyt.2015.00090  1
2015 Uresti-Cabrera LA, Diaz R, Vaca-Palomares I, Fernandez-Ruiz J. The effect of spatial working memory deterioration on strategic visuomotor learning across aging Behavioural Neurology. 2015. DOI: 10.1155/2015/512617  1
2015 Hernandez-Castillo CR, Galvez V, Mercadillo RE, Díaz R, Yescas P, Martinez L, Ochoa A, Velazquez-Perez L, Fernandez-Ruiz J. Functional connectivity changes related to cognitive and motor performance in spinocerebellar ataxia type 2 Movement Disorders. 30: 1391-1399. DOI: 10.1002/mds.26320  1
2014 Hernandez-Castillo CR, Galvez V, Morgado-Valle C, Fernandez-Ruiz J. Whole-brain connectivity analysis and classification of spinocerebellar ataxia type 7 by functional MRI. Cerebellum & Ataxias. 1: 2. PMID 26331026 DOI: 10.1186/2053-8871-1-2  1
2014 Gutiérrez-Garralda JM, Hernandez-Castillo CR, Barrios FA, Pasaye EH, Fernandez-Ruiz J. Neural correlates of spatial working memory manipulation in a sequential Vernier discrimination task. Neuroreport. 25: 1418-23. PMID 25350139 DOI: 10.1097/WNR.0000000000000280  1
2014 Witiuk K, Fernandez-Ruiz J, McKee R, Alahyane N, Coe BC, Melanson M, Munoz DP. Cognitive deterioration and functional compensation in ALS measured with fMRI using an inhibitory task. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14260-71. PMID 25339740 DOI: 10.1523/JNEUROSCI.1111-14.2014  1
2014 Tam A, Luedke AC, Walsh JJ, Fernandez-Ruiz J, Garcia A. Effects of reaction time variability and age on brain activity during Stroop task performance. Brain Imaging and Behavior. PMID 25280971 DOI: 10.1007/s11682-014-9323-y  1
2014 Mercadillo RE, Galvez V, Díaz R, Hernández-Castillo CR, Campos-Romo A, Boll MC, Pasaye EH, Fernandez-Ruiz J. Parahippocampal gray matter alterations in Spinocerebellar Ataxia Type 2 identified by voxel based morphometry. Journal of the Neurological Sciences. 347: 50-8. PMID 25263602 DOI: 10.1016/j.jns.2014.09.018  1
2014 Velázquez-Pérez L, Rodríguez-Labrada R, Cruz-Rivas EM, Fernández-Ruiz J, Vaca-Palomares I, Lilia-Campins J, Cisneros B, Peña-Acosta A, Vázquez-Mojena Y, Diaz R, Magaña-Aguirre JJ, Cruz-Mariño T, Estupiñán-Rodríguez A, Laffita-Mesa JM, González-Piña R, et al. Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the disease. Cerebellum (London, England). 13: 568-79. PMID 24906824 DOI: 10.1007/s12311-014-0574-3  0.6
2014 Galvez V, Diaz R, Hernandez-Castillo CR, Campos-Romo A, Fernandez-Ruiz J. Olfactory performance in spinocerebellar ataxia type 7 patients. Parkinsonism & Related Disorders. 20: 499-502. PMID 24629799 DOI: 10.1016/j.parkreldis.2014.01.024  1
2013 Hernandez-Castillo CR, Alcauter S, Galvez V, Barrios FA, Yescas P, Ochoa A, Garcia L, Diaz R, Gao W, Fernandez-Ruiz J. Disruption of visual and motor connectivity in spinocerebellar ataxia type 7. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1708-16. PMID 23926060 DOI: 10.1002/mds.25618  1
2013 Gutierrez-Garralda JM, Moreno-Briseño P, Boll MC, Morgado-Valle C, Campos-Romo A, Diaz R, Fernandez-Ruiz J. The effect of Parkinson's disease and Huntington's disease on human visuomotor learning. The European Journal of Neuroscience. 38: 2933-40. PMID 23802680 DOI: 10.1111/ejn.12288  1
2013 Vaca-Palomares I, Díaz R, Rodríguez-Labrada R, Medrano-Montero J, Vázquez-Mojena Y, Velázquez-Pérez L, Fernandez-Ruiz J. Spinocerebellar ataxia type 2 neurodegeneration differentially affects error-based and strategic-based visuomotor learning. Cerebellum (London, England). 12: 848-55. PMID 23754233 DOI: 10.1007/s12311-013-0496-5  1
2013 Lillicrap TP, Moreno-Briseño P, Diaz R, Tweed DB, Troje NF, Fernandez-Ruiz J. Adapting to inversion of the visual field: a new twist on an old problem. Experimental Brain Research. 228: 327-39. PMID 23700129 DOI: 10.1007/s00221-013-3565-6  1
2012 Beltran-Parrazal L, Fernandez-Ruiz J, Toledo R, Manzo J, Morgado-Valle C. Inhibition of endoplasmic reticulum Ca²⁺ ATPase in preBötzinger complex of neonatal rat does not affect respiratory rhythm generation. Neuroscience. 224: 116-24. PMID 22906476 DOI: 10.1016/j.neuroscience.2012.08.016  1
2012 Campos-Romo A, Ojeda-Flores R, Moreno-Briseño P, Vergara P, Segovia J, Carrillo-Ruiz JD, Fernandez-Ruiz J. Behavioral improvement in MPTP-treated nonhuman primates in the HALLWAY task after transfer of TH cDNA to host astrocytes. Acta Neurobiologiae Experimentalis. 72: 166-76. PMID 22810218  1
2011 Fernandez-Ruiz J, Wong W, Armstrong IT, Flanagan JR. Relation between reaction time and reach errors during visuomotor adaptation. Behavioural Brain Research. 219: 8-14. PMID 21138745 DOI: 10.1016/j.bbr.2010.11.060  1
2010 Moreno-Briseño P, Díaz R, Campos-Romo A, Fernandez-Ruiz J. Sex-related differences in motor learning and performance. Behavioral and Brain Functions : Bbf. 6: 74. PMID 21182785 DOI: 10.1186/1744-9081-6-74  1
2010 Velázquez-Perez L, Rodríguez-Labrada R, Canales-Ochoa N, Sanchez-Cruz G, Fernandez-Ruiz J, Montero JM, Aguilera-Rodríguez R, Diaz R, Almaguer-Mederos LE, Truitz AP. Progression markers of Spinocerebellar ataxia 2. A twenty years neurophysiological follow up study. Journal of the Neurological Sciences. 290: 22-6. PMID 20070987 DOI: 10.1016/j.jns.2009.12.013  1
2009 Velázquez-Perez L, Díaz R, Pérez-González R, Canales N, Rodríguez-Labrada R, Medrano J, Sánchez G, Almaguer-Mederos L, Torres C, Fernandez-Ruiz J. Motor decline in clinically presymptomatic spinocerebellar ataxia type 2 gene carriers. Plos One. 4: e5398. PMID 19401771 DOI: 10.1371/journal.pone.0005398  1
2009 Campos-Romo A, Ojeda-Flores R, Moreno-Briseño P, Fernandez-Ruiz J. Quantitative evaluation of MPTP-treated nonhuman parkinsonian primates in the HALLWAY task. Journal of Neuroscience Methods. 177: 361-8. PMID 19022292 DOI: 10.1016/j.jneumeth.2008.10.026  1
2007 Fernandez-Ruiz J, Velásquez-Perez L, Díaz R, Drucker-Colín R, Pérez-González R, Canales N, Sánchez-Cruz G, Martínez-Góngora E, Medrano Y, Almaguer-Mederos L, Seifried C, Auburger G. Prism adaptation in spinocerebellar ataxia type 2. Neuropsychologia. 45: 2692-8. PMID 17507059 DOI: 10.1016/j.neuropsychologia.2007.04.006  1
2007 Barrios FA, Gonzalez L, Favila R, Alonso ME, Salgado PM, Diaz R, Fernandez-Ruiz J. Olfaction and neurodegeneration in HD. Neuroreport. 18: 73-6. PMID 17259864 DOI: 10.1097/WNR.0b013e3280102302  1
2007 Fernandez-Ruiz J, Goltz HC, DeSouza JF, Vilis T, Crawford JD. Human parietal "reach region" primarily encodes intrinsic visual direction, not extrinsic movement direction, in a visual motor dissociation task. Cerebral Cortex (New York, N.Y. : 1991). 17: 2283-92. PMID 17215478 DOI: 10.1093/cercor/bhl137  1
2006 Velázquez-Pérez L, Fernandez-Ruiz J, Díaz R, González RP, Ochoa NC, Cruz GS, Mederos LE, Góngora EM, Hudson R, Drucker-Colin R. Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. Journal of Neurology. 253: 1165-9. PMID 16609806 DOI: 10.1007/s00415-006-0183-2  1
2006 Fernandez-Ruiz J, Diaz R, Moreno-Briseño P, Campos-Romo A, Ojeda R. Rapid topographical plasticity of the visuomotor spatial transformation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 1986-90. PMID 16481431 DOI: 10.1523/JNEUROSCI.4023-05.2006  1
2004 Fernández-Ruiz J, Díaz R, Aguilar C, Hall-Haro C. Decay of prism aftereffects under passive and active conditions. Brain Research. Cognitive Brain Research. 20: 92-7. PMID 15130593 DOI: 10.1016/j.cogbrainres.2004.01.007  1
2003 Fernandez-Ruiz J, Diaz R, Hall-Haro C, Vergara P, Mischner J, Nuñez L, Drucker-Colin R, Ochoa A, Alonso ME. Normal prism adaptation but reduced after-effect in basal ganglia disorders using a throwing task. The European Journal of Neuroscience. 18: 689-94. PMID 12911765 DOI: 10.1046/j.1460-9568.2003.02785.x  1
2003 Fernandez-Ruiz J, Díaz R, Hall-Haro C, Vergara P, Fiorentini A, Nuñez L, Drucker-Colín R, Ochoa A, Yescas P, Rasmussen A, Alonso ME. Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. Neuroreport. 14: 1339-41. PMID 12876469 DOI: 10.1097/01.wnr.0000077551.91466.d3  1
2001 Fernandez-Ruiz J, Wang J, Aigner TG, Mishkin M. Visual habit formation in monkeys with neurotoxic lesions of the ventrocaudal neostriatum. Proceedings of the National Academy of Sciences of the United States of America. 98: 4196-201. PMID 11274442 DOI: 10.1073/pnas.061022098  1
2000 Fernández-Ruiz J, Hall-Haro C, Díaz R, Mischner J, Vergara P, Lopez-Garcia JC. Learning motor synergies makes use of information on muscular load. Learning & Memory (Cold Spring Harbor, N.Y.). 7: 193-8. PMID 10940319 DOI: 10.1101/lm.7.4.193  1
2000 Fernández-Ruiz J, Hall C, Vergara P, Díiaz R. Prism adaptation in normal aging: slower adaptation rate and larger aftereffect. Brain Research. Cognitive Brain Research. 9: 223-6. PMID 10808133  0.44
1999 Fernández-Ruiz J, Doudet D, Aigner TG. Spatial memory improvement by levodopa in parkinsonian MPTP-treated monkeys. Psychopharmacology. 147: 104-7. PMID 10591875  0.52
1995 Fernandez-Ruiz J, Doudet DJ, Aigner TG. Long-term cognitive impairment in MPTP-treated rhesus monkeys. Neuroreport. 7: 102-4. PMID 8742427  1
1993 Fernandez-Ruiz J, Miranda MI, Bermúdez-Rattoni F, Drucker-Colín R. Effects of catecholaminergic depletion of the amygdala and insular cortex on the potentiation of odor by taste aversions. Behavioral and Neural Biology. 60: 189-91. PMID 8297313 DOI: 10.1016/0163-1047(93)90314-8  1
1993 López-García JC, Fernández-Ruiz J, Escobar ML, Bermúdez-Rattoni F, Tapia R. Effects of excitotoxic lesions of the nucleus basalis magnocellularis on conditioned taste aversion and inhibitory avoidance in the rat. Pharmacology, Biochemistry, and Behavior. 45: 147-52. PMID 8100072 DOI: 10.1016/0091-3057(93)90098-E  1
1991 Fernández-Ruiz J, Escobar ML, Piña AL, Diaz-Cintra S, Cintra-McGlone FL, Bermúdez-Rattoni F. Time-dependent recovery of taste aversion learning by fetal brain transplants in gustatory neocortex-lesioned rats. Behavioral and Neural Biology. 55: 179-93. PMID 1647761 DOI: 10.1016/0163-1047(91)80138-5  1
1990 López-García JC, Fernández-Ruiz J, Bermúdez-Rattoni F, Tapia R. Correlation between acetylcholine release and recovery of conditioned taste aversion induced by fetal neocortex grafts. Brain Research. 523: 105-10. PMID 1976417 DOI: 10.1016/0006-8993(90)91641-S  1
Low-probability matches
2019 Fernandez-Ruiz J, Hakvoort Schwerdtfeger RM, Alahyane N, Brien DC, Coe BC, Munoz DP. Dorsolateral prefrontal cortex hyperactivity during inhibitory control in children with ADHD in the antisaccade task. Brain Imaging and Behavior. PMID 31493141 DOI: 10.1007/s11682-019-00196-3  0.2
2019 Ramirez-Garcia G, Harrison KA, Fernandez-Ruiz J, Nashed JY, Cook DJ. Stroke Longitudinal Volumetric Measures Correlate with the Behavioral Score in Non-Human Primates. Neuroscience. 397: 41-55. PMID 30481566 DOI: 10.1016/j.neuroscience.2018.11.026  0.2
2017 Fernandez-Ruiz J, Peltsch AJ, Alayhane N, Brien DC, Coe BC, Garcia A, Munoz DP. Age related prefrontal compensatory mechanisms for inhibitory control in the antisaccade task. Neuroimage. PMID 28988829 DOI: 10.1016/j.neuroimage.2017.10.001  0.2
2019 Manno FAM, Lau C, Fernandez-Ruiz J, Manno SH, Cheng SH, Barrios FA. The human amygdala disconnecting from auditory cortex preferentially discriminates musical sound of uncertain emotion by altering hemispheric weighting. Scientific Reports. 9: 14787. PMID 31615998 DOI: 10.1038/s41598-019-50042-1  0.16
2019 Manno FAM, Fernandez-Ruiz J, Manno SHC, Cheng SH, Lau C, Barrios FA. Sparse Sampling of Silence Type I Errors With an Emphasis on Primary Auditory Cortex. Frontiers in Neuroscience. 13: 516. PMID 31213968 DOI: 10.3389/fnins.2019.00516  0.16
2011 Alcauter S, Barrios FA, Díaz R, Fernández-Ruiz J. Gray and white matter alterations in spinocerebellar ataxia type 7: an in vivo DTI and VBM study. Neuroimage. 55: 1-7. PMID 21147232 DOI: 10.1016/j.neuroimage.2010.12.014  0.16
2015 Gómez-Gálvez Y, Palomo-Garo C, Fernández-Ruiz J, García C. Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 25863279 DOI: 10.1016/j.pnpbp.2015.03.017  0.12
2015 Feliú A, Moreno-Martet M, Mecha M, Carrillo-Salinas FJ, de Lago E, Fernández-Ruiz J, Guaza C. A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis. British Journal of Pharmacology. 172: 3579-95. PMID 25857324 DOI: 10.1111/bph.13159  0.12
2015 Espejo-Porras F, Piscitelli F, Verde R, Ramos JA, Di Marzo V, de Lago E, Fernández-Ruiz J. Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 10: 233-44. PMID 25819934 DOI: 10.1007/s11481-015-9602-4  0.12
2015 Morales P, Blasco-Benito S, Andradas C, Gómez-Cañas M, Flores JM, Goya P, Fernández-Ruiz J, Sánchez C, Jagerovic N. Selective, nontoxic CB(2) cannabinoid o-quinone with in vivo activity against triple-negative breast cancer. Journal of Medicinal Chemistry. 58: 2256-64. PMID 25671648 DOI: 10.1021/acs.jmedchem.5b00078  0.12
2015 García MC, Cinquina V, Palomo-Garo C, Rábano A, Fernández-Ruiz J. Identification of CB₂ receptors in human nigral neurons that degenerate in Parkinson's disease. Neuroscience Letters. 587: 1-4. PMID 25481767 DOI: 10.1016/j.neulet.2014.12.003  0.12
2014 Moreno-Martet M, Espejo-Porras F, Fernández-Ruiz J, de Lago E. Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis. Cns Neuroscience & Therapeutics. 20: 809-15. PMID 24703394 DOI: 10.1111/cns.12262  0.12
2014 Rodríguez-Cueto C, Benito C, Romero J, Hernández-Gálvez M, Gómez-Ruiz M, Fernández-Ruiz J. Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 81: 149-59. PMID 24642775 DOI: 10.1159/000358127  0.12
2014 Fernández-Fernández C, Callado LF, Girón R, Sánchez E, Erdozain AM, López-Moreno JA, Morales P, Rodríguez de Fonseca F, Fernández-Ruiz J, Goya P, Meana JJ, Martín MI, Jagerovic N. Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results. Drug Design, Development and Therapy. 8: 263-77. PMID 24591816 DOI: 10.2147/DDDT.S55045  0.12
2014 González-Naranjo P, Pérez-Macias N, Campillo NE, Pérez C, Arán VJ, Girón R, Sánchez-Robles E, Martín MI, Gómez-Cañas M, García-Arencibia M, Fernández-Ruiz J, Páez JA. Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease. European Journal of Medicinal Chemistry. 73: 56-72. PMID 24378710 DOI: 10.1016/j.ejmech.2013.11.026  0.12
2014 Rodríguez-Cueto C, Benito C, Fernández-Ruiz J, Romero J, Hernández-Gálvez M, Gómez-Ruiz M. Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias. British Journal of Pharmacology. 171: 1472-89. PMID 23808969 DOI: 10.1111/bph.12283  0.12
2013 Morales P, Vara D, Goméz-Cañas M, Zúñiga MC, Olea-Azar C, Goya P, Fernández-Ruiz J, Díaz-Laviada I, Jagerovic N. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity. European Journal of Medicinal Chemistry. 70: 111-9. PMID 24141201 DOI: 10.1016/j.ejmech.2013.09.043  0.12
2013 Valdeolivas S, Pazos MR, Bisogno T, Piscitelli F, Iannotti FA, Allarà M, Sagredo O, Di Marzo V, Fernández-Ruiz J. The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG. Cell Death & Disease. 4: e862. PMID 24136226 DOI: 10.1038/cddis.2013.387  0.12
2013 Gómez del Rio MA, Sánchez-Reus MI, Iglesias I, Pozo MA, García-Arencibia M, Fernández-Ruiz J, García-García L, Delgado M, Benedí J. Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson's Disease. Cns & Neurological Disorders Drug Targets. 12: 665-79. PMID 23469842  0.12
2013 Alvarado M, Decara J, Luque MJ, Hernandez-Folgado L, Gómez-Cañas M, Gómez-Ruiz M, Fernández-Ruiz J, Elguero J, Jagerovic N, Serrano A, Goya P, de Fonseca FR. Novel antiobesity agents: synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21. Bioorganic & Medicinal Chemistry. 21: 1708-16. PMID 23434135 DOI: 10.1016/j.bmc.2013.01.055  0.12
2012 Valdeolivas S, Satta V, Pertwee RG, Fernández-Ruiz J, Sagredo O. Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors. Acs Chemical Neuroscience. 3: 400-6. PMID 22860209 DOI: 10.1021/cn200114w  0.12
2012 Pazos MR, Cinquina V, Gómez A, Layunta R, Santos M, Fernández-Ruiz J, Martínez-Orgado J. Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Neuropharmacology. 63: 776-83. PMID 22659086 DOI: 10.1016/j.neuropharm.2012.05.034  0.12
2012 de Lago E, Moreno-Martet M, Cabranes A, Ramos JA, Fernández-Ruiz J. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects. Neuropharmacology. 62: 2299-308. PMID 22342378 DOI: 10.1016/j.neuropharm.2012.01.030  0.12
2012 Cumella J, Hernández-Folgado L, Girón R, Sánchez E, Morales P, Hurst DP, Gómez-Cañas M, Gómez-Ruiz M, Pinto DC, Goya P, Reggio PH, Martin MI, Fernández-Ruiz J, Silva AM, Jagerovic N. Chromenopyrazoles: non-psychoactive and selective CB₁ cannabinoid agonists with peripheral antinociceptive properties. Chemmedchem. 7: 452-63. PMID 22302767 DOI: 10.1002/cmdc.201100568  0.12
2012 Moreno-Martet M, Mestre L, Loría F, Guaza C, Fernández-Ruiz J, de Lago E. Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: relevance for in vitro studies with cannabinoids in motor neuron diseases. Neuroscience Letters. 508: 67-72. PMID 22206832 DOI: 10.1016/j.neulet.2011.12.020  0.12
2011 Sagredo O, Pazos MR, Satta V, Ramos JA, Pertwee RG, Fernández-Ruiz J. Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease. Journal of Neuroscience Research. 89: 1509-18. PMID 21674569 DOI: 10.1002/jnr.22682  0.12
2011 García C, Palomo-Garo C, García-Arencibia M, Ramos J, Pertwee R, Fernández-Ruiz J. Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease. British Journal of Pharmacology. 163: 1495-506. PMID 21323909 DOI: 10.1111/j.1476-5381.2011.01278.x  0.12
2010 Innamorato NG, Jazwa A, Rojo AI, García C, Fernández-Ruiz J, Grochot-Przeczek A, Stachurska A, Jozkowicz A, Dulak J, Cuadrado A. Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1. Plos One. 5: e11838. PMID 20676377 DOI: 10.1371/journal.pone.0011838  0.12
2010 Fernández-Ruiz J, García C, Sagredo O, Gómez-Ruiz M, de Lago E. The endocannabinoid system as a target for the treatment of neuronal damage. Expert Opinion On Therapeutic Targets. 14: 387-404. PMID 20230193 DOI: 10.1517/14728221003709792  0.12
2010 Castillo A, Tolón MR, Fernández-Ruiz J, Romero J, Martinez-Orgado J. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors. Neurobiology of Disease. 37: 434-40. PMID 19900555 DOI: 10.1016/j.nbd.2009.10.023  0.12
2009 de Lago E, Gómez-Ruiz M, Moreno-Martet M, Fernández-Ruiz J. Cannabinoids, multiple sclerosis and neuroprotection. Expert Review of Clinical Pharmacology. 2: 645-60. PMID 22112258 DOI: 10.1586/ecp.09.42  0.12
2009 García-Arencibia M, García C, Fernández-Ruiz J. Cannabinoids and Parkinson's disease. Cns & Neurological Disorders Drug Targets. 8: 432-9. PMID 19839934  0.12
2009 Orgado JM, Fernández-Ruiz J, Romero J. The endocannabinoid system in neuropathological states. International Review of Psychiatry (Abingdon, England). 21: 172-80. PMID 19367511 DOI: 10.1080/09540260902782828  0.12
2009 Rubio M, de Miguel R, Fernández-Ruiz J, Gutiérrez-López D, Carai MA, Ramos JA. Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas. Drug and Alcohol Dependence. 99: 354-8. PMID 18922654 DOI: 10.1016/j.drugalcdep.2008.08.004  0.12
2008 Gómez M, Hernández M, Fernández-Ruiz J. Cannabinoid signaling system: does it play a function in cell proliferation and migration, neuritic elongation and guidance and synaptogenesis during brain ontogenesis? Cell Adhesion & Migration. 2: 246-8. PMID 19262157  0.12
2008 García-Arencibia M, Ferraro L, Tanganelli S, Fernández-Ruiz J. Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats. Neuroscience Letters. 438: 10-3. PMID 18457923 DOI: 10.1016/j.neulet.2008.04.041  0.12
2008 Gómez M, Hernández ML, Pazos MR, Tolón RM, Romero J, Fernández-Ruiz J. Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance. Neuroscience. 153: 687-99. PMID 18400407 DOI: 10.1016/j.neuroscience.2008.02.038  0.12
2008 Rubio M, Fernández-Ruiz J, de Miguel R, Maestro B, Michael Walker J, Ramos JA. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. Neuropharmacology. 54: 976-88. PMID 18371990 DOI: 10.1016/j.neuropharm.2008.02.005  0.12
2008 Fernández-Ruiz J, Pazos MR, García-Arencibia M, Sagredo O, Ramos JA. Role of CB2 receptors in neuroprotective effects of cannabinoids. Molecular and Cellular Endocrinology. 286: S91-6. PMID 18291574 DOI: 10.1016/j.mce.2008.01.001  0.12
2007 de Lago E, Fernández-Ruiz J. Cannabinoids and neuroprotection in motor-related disorders. Cns & Neurological Disorders Drug Targets. 6: 377-87. PMID 18220777  0.12
2007 Sagredo O, García-Arencibia M, de Lago E, Finetti S, Decio A, Fernández-Ruiz J. Cannabinoids and neuroprotection in basal ganglia disorders. Molecular Neurobiology. 36: 82-91. PMID 17952653 DOI: 10.1007/s12035-007-0004-3  0.12
2007 Gómez M, Hernández M, Fernández-Ruiz J. The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brain. Brain Research. 1145: 48-55. PMID 17320842 DOI: 10.1016/j.brainres.2007.01.102  0.12
2007 de Lago E, Ortega-Gutiérrez S, Ramos JA, López Rodríguez ML, Fernández-Ruiz J. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions. Life Sciences. 80: 979-88. PMID 17173937 DOI: 10.1016/j.lfs.2006.11.029  0.12
2007 Fernández-Ruiz J, Romero J, Velasco G, Tolón RM, Ramos JA, Guzmán M. Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends in Pharmacological Sciences. 28: 39-45. PMID 17141334 DOI: 10.1016/j.tips.2006.11.001  0.12
2006 Lastres-Becker I, Fernández-Ruiz J. An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments. Current Medicinal Chemistry. 13: 3705-18. PMID 17168732  0.12
2006 De Lago E, Gustafsson SB, Fernández-Ruiz J, Nilsson J, Jacobsson SO, Fowler CJ. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations. Journal of Neurochemistry. 99: 677-88. PMID 16899063 DOI: 10.1111/j.1471-4159.2006.04104.x  0.12
2006 Cabranes A, Pryce G, Baker D, Fernández-Ruiz J. Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice. Brain Research. 1107: 199-205. PMID 16822488 DOI: 10.1016/j.brainres.2006.06.001  0.12
2006 González S, Scorticati C, García-Arencibia M, de Miguel R, Ramos JA, Fernández-Ruiz J. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease. Brain Research. 1073: 209-19. PMID 16412990 DOI: 10.1016/j.brainres.2005.12.014  0.12
2006 Sagredo O, Ramos JA, Fernández-Ruiz J, Rodríguez ML, de Miguel R. Chronic Delta9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex. Naunyn-Schmiedeberg's Archives of Pharmacology. 372: 313-7. PMID 16385404 DOI: 10.1007/s00210-005-0026-1  0.12
2006 de Lago E, Fernández-Ruiz J, Ortega-Gutiérrez S, Cabranes A, Pryce G, Baker D, López-Rodríguez M, Ramos JA. UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 7-18. PMID 16006105 DOI: 10.1016/j.euroneuro.2005.06.001  0.12
2005 Fernández-Ruiz J, Gonzáles S. Cannabinoid control of motor function at the basal ganglia. Handbook of Experimental Pharmacology. 479-507. PMID 16596785  0.12
2005 Cabranes A, Venderova K, de Lago E, Fezza F, Sánchez A, Mestre L, Valenti M, García-Merino A, Ramos JA, Di Marzo V, Fernández-Ruiz J. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Neurobiology of Disease. 20: 207-17. PMID 16242629 DOI: 10.1016/j.nbd.2005.03.002  0.12
2005 Ramos JA, González S, Sagredo O, Gómez-Ruiz M, Fernández-Ruiz J. Therapeutic potential of the endocannabinoid system in the brain. Mini Reviews in Medicinal Chemistry. 5: 609-17. PMID 16026307  0.12
2005 de Lago E, Urbani P, Ramos JA, Di Marzo V, Fernández-Ruiz J. Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease. Brain Research. 1050: 210-6. PMID 15975564 DOI: 10.1016/j.brainres.2005.05.024  0.12
2005 González S, Cebeira M, Fernández-Ruiz J. Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacology, Biochemistry, and Behavior. 81: 300-18. PMID 15919107 DOI: 10.1016/j.pbb.2005.01.028  0.12
2004 Fernández-Ruiz J, Gómez M, Hernández M, de Miguel R, Ramos JA. Cannabinoids and gene expression during brain development. Neurotoxicity Research. 6: 389-401. PMID 15545023  0.12
2004 Gomes-da-Silva J, de Miguel R, Fernández-Ruiz J, Summavielle T, Tavares MA. Effects of neonatal exposure to methamphetamine: catecholamine levels in brain areas of the developing rat. Annals of the New York Academy of Sciences. 1025: 602-11. PMID 15542769 DOI: 10.1196/annals.1316.075  0.12
2004 González S, Valenti M, de Miguel R, Fezza F, Fernández-Ruiz J, Di Marzo V, Ramos JA. Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. British Journal of Pharmacology. 143: 455-64. PMID 15371286 DOI: 10.1038/sj.bjp.0705963  0.12
2004 Suárez I, Bodega G, Fernández-Ruiz J, Ramos JA, Rubio M, Fernández B. Down-regulation of the AMPA glutamate receptor subunits GluR1 and GluR2/3 in the rat cerebellum following pre- and perinatal delta9-tetrahydrocannabinol exposure. Cerebellum (London, England). 3: 66-74. PMID 15233572 DOI: 10.1080/14734220310017230  0.12
2004 González S, Fernández-Ruiz J, Di Marzo V, Hernández M, Arévalo C, Nicanor C, Cascio MG, Ambrosio E, Ramos JA. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. Drug and Alcohol Dependence. 74: 159-70. PMID 15099659 DOI: 10.1016/j.drugalcdep.2003.12.011  0.12
2004 de Lago E, de Miguel R, Lastres-Becker I, Ramos JA, Fernández-Ruiz J. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. Brain Research. 1007: 152-9. PMID 15064146 DOI: 10.1016/j.brainres.2004.02.016  0.12
2004 Sousa JC, Grandela C, Fernández-Ruiz J, de Miguel R, de Sousa L, Magalhães AI, Saraiva MJ, Sousa N, Palha JA. Transthyretin is involved in depression-like behaviour and exploratory activity. Journal of Neurochemistry. 88: 1052-8. PMID 15009661 DOI: 10.1046/j.1471-4159.2003.02309.x  0.12
2003 Gómez M, Hernández M, Johansson B, de Miguel R, Ramos JA, Fernández-Ruiz J. Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain. Brain Research. Developmental Brain Research. 147: 201-7. PMID 15068010  0.12
2003 González B, de Miguel R, Martín S, Pérez-Rosado A, Romero J, García-Lecumberri C, Fernández-Ruiz J, Ramos JA, Ambrosio E. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior. Pharmacology, Biochemistry, and Behavior. 75: 577-84. PMID 12895675  0.12
2003 González S, Schmid PC, Fernández-Ruiz J, Krebsbach R, Schmid HH, Ramos JA. Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats. Addiction Biology. 8: 159-66. PMID 12850774 DOI: 10.1080/1355621031000117383  0.12
2003 López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Fowler CJ, Tiger G, de Lago E, Fernández-Ruiz J, Ramos JA. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors. European Journal of Medicinal Chemistry. 38: 403-12. PMID 12750028  0.12
2003 López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Fowler CJ, Tiger G, de Lago E, Fernández-Ruiz J, Ramos JA. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase. Journal of Medicinal Chemistry. 46: 1512-22. PMID 12672252 DOI: 10.1021/jm0210818  0.12
2003 Lastres-Becker I, de Miguel R, De Petrocellis L, Makriyannis A, Di Marzo V, Fernández-Ruiz J. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease. Journal of Neurochemistry. 84: 1097-109. PMID 12603833 DOI: 10.1046/j.1471-4159.2003.01595.x  0.12
2002 Ramos JA, De Miguel R, Cebeira M, Hernandez M, Fernández-Ruiz J. Exposure to cannabinoids in the development of endogenous cannabinoid system. Neurotoxicity Research. 4: 363-72. PMID 12829425 DOI: 10.1080/1029842021000010893  0.12
2002 Pérez-Rosado A, Gómez M, Manzanares J, Ramos JA, Fernández-Ruiz J. Changes in prodynorphin and POMC gene expression in several brain regions of rat fetuses prenatally exposed to Delta(9)-tetrahydrocannabinol. Neurotoxicity Research. 4: 211-8. PMID 12829401 DOI: 10.1080/10298420290023936  0.12
2002 Lastres-Becker I, Gómez M, De Miguel R, Ramos JA, Fernández-Ruiz J. Loss of cannabinoid CB(1) receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington's disease. Neurotoxicity Research. 4: 601-608. PMID 12709298 DOI: 10.1080/10298420290030514  0.12
2002 González S, Cascio MG, Fernández-Ruiz J, Fezza F, Di Marzo V, Ramos JA. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Research. 954: 73-81. PMID 12393235  0.12
2002 Romero J, Lastres-Becker I, de Miguel R, Berrendero F, Ramos JA, Fernández-Ruiz J. The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects. Pharmacology & Therapeutics. 95: 137-52. PMID 12182961  0.12
2002 de Lago E, Fernández-Ruiz J, Ortega-Gutiérrez S, Viso A, López-Rodríguez ML, Ramos JA. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. European Journal of Pharmacology. 449: 99-103. PMID 12163112  0.12
2002 Gomes-da-Silva J, Pérez-Rosado A, de Miguel R, Fernández-Ruiz J, Silva MC, Tavares MA. Prenatal exposure to methamphetamine in the rat: ontogeny of tyrosine hydroxylase mRNA expression in mesencephalic dopaminergic neurons. Annals of the New York Academy of Sciences. 965: 68-77. PMID 12105086  0.12
2002 Hansen HH, Azcoitia I, Pons S, Romero J, García-Segura LM, Ramos JA, Hansen HS, Fernández-Ruiz J. Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity. Journal of Neurochemistry. 82: 154-8. PMID 12091476  0.12
2002 Fernández-Ruiz J, Lastres-Becker I, Cabranes A, González S, Ramos JA. Endocannabinoids and basal ganglia functionality. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 66: 257-67. PMID 12052041 DOI: 10.1054/plef.2001.0350  0.12
2002 Lastres-Becker I, Hansen HH, Berrendero F, De Miguel R, Pérez-Rosado A, Manzanares J, Ramos JA, Fernández-Ruiz J. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease. Synapse (New York, N.Y.). 44: 23-35. PMID 11842443 DOI: 10.1002/syn.10054  0.12
2001 López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Lastres-Becker I, González S, Fernández-Ruiz J, Ramos JA. Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. Journal of Medicinal Chemistry. 44: 4505-8. PMID 11741470  0.12
2001 Lastres-Becker I, Fezza F, Cebeira M, Bisogno T, Ramos JA, Milone A, Fernández-Ruiz J, Di Marzo V. Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease. Neuroreport. 12: 2125-9. PMID 11447320  0.12
2001 Berrendero F, Sánchez A, Cabranes A, Puerta C, Ramos JA, García-Merino A, Fernández-Ruiz J. Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis. Synapse (New York, N.Y.). 41: 195-202. PMID 11391780 DOI: 10.1002/syn.1075  0.12
2000 González S, Mauriello-Romanazzi G, Berrendero F, Ramos JA, Franzoni MF, Fernández-Ruiz J. Decreased cannabinoid CB1 receptor mRNA levels and immunoreactivity in pituitary hyperplasia induced by prolonged exposure to estrogens. Pituitary. 3: 221-6. PMID 11788009  0.12
2000 Pérez-Rosado A, Manzanares J, Fernández-Ruiz J, Ramos JA. Prenatal Delta(9)-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences. Brain Research. Developmental Brain Research. 120: 77-81. PMID 10727732  0.12
2000 Hernández M, Berrendero F, Suárez I, García-Gil L, Cebeira M, Mackie K, Ramos JA, Fernández-Ruiz J. Cannabinoid CB(1) receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme. Brain Research. 857: 56-65. PMID 10700552  0.12
1999 Fernández-Ruiz J, Díaz R. Prism adaptation and aftereffect: specifying the properties of a procedural memory system. Learning & Memory (Cold Spring Harbor, N.Y.). 6: 47-53. PMID 10355523  0.12
1995 Vela G, Fuentes JA, Bonnin A, Fernández-Ruiz J, Ruiz-Gayo M. Perinatal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) leads to changes in opioid-related behavioral patterns in rats. Brain Research. 680: 142-7. PMID 7663970  0.12
1993 Fernández-Ruiz J, Guzmán R, Martínez MD, Miranda MI, Bermúdez-Rattoni F, Drucker-Colín R. Adrenal medullary grafts restore olfactory deficits and catecholamine levels of 6-OHDA amygdala lesioned animals. Journal of Neural Transplantation & Plasticity. 4: 289-97. PMID 7948179 DOI: 10.1155/NP.1993.289  0.12
1990 Paredes RG, Piña AL, Fernández-Ruiz J, Bermúdez-Rattoni F. Fetal brain transplants induce recovery of male sexual behavior in medial preoptic area-lesioned rats. Brain Research. 523: 331-6. PMID 1976027  0.12
1988 Cabrera R, Mayor P, Fernández-Ruiz J, Calle C. Insulin binding and action on adipocytes from female rats with experimentally induced chronic hyperprolactinemia. Molecular and Cellular Endocrinology. 58: 167-73. PMID 3061857  0.12
2012 Sagredo O, Pazos MR, Valdeolivas S, Fernandez-Ruiz J. Cannabinoids: novel medicines for the treatment of Huntington's disease. Recent Patents On Cns Drug Discovery. 7: 41-8. PMID 22280340  0.01
2006 Millns PJ, Chimenti M, Ali N, Ryland E, de Lago E, Fernandez-Ruiz J, Chapman V, Kendall DA. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors. The European Journal of Neuroscience. 24: 3489-95. PMID 17229097 DOI: 10.1111/j.1460-9568.2006.05236.x  0.04
1994 Romero J, Garcia L, Ramos JA, Fernandez-Ruiz JJ. The putative cannabinoid receptor ligand, anandamide, stimulates hypothalamic tyrosine hydroxylase activity and inhibits prolactin release Neuroendocrinology Letters. 16: 159-164.  0.08
2020 Champagne AA, Coverdale NS, Fernandez-Ruiz J, Mark CI, Cook DJ. Compromised resting cerebral metabolism after sport-related concussion: A calibrated MRI study. Brain Imaging and Behavior. PMID 32307673 DOI: 10.1007/s11682-019-00240-2  0.04
2020 Coverdale NS, Fernandez-Ruiz J, Champagne AA, Mark CI, Cook DJ. Co-localized impaired regional cerebrovascular reactivity in chronic concussion is associated with BOLD activation differences during a working memory task. Brain Imaging and Behavior. PMID 31903527 DOI: 10.1007/s11682-019-00194-5  0.04
2019 Champagne AA, Coverdale NS, Nashed JY, Fernandez-Ruiz J, Cook DJ. Resting CMRO fluctuations show persistent network hyper-connectivity following exposure to sub-concussive collisions. Neuroimage. Clinical. 22: 101753. PMID 30884366 DOI: 10.1016/j.nicl.2019.101753  0.04
2017 Velázquez-Pérez LC, Rodríguez-Labrada R, Fernandez-Ruiz J. Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches. Frontiers in Neurology. 8: 472. PMID 28955296 DOI: 10.3389/fneur.2017.00472  0.04
2015 Fernández-Ruiz J, Romero J, Ramos JA. Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others. Handbook of Experimental Pharmacology. 231: 233-59. PMID 26408163 DOI: 10.1007/978-3-319-20825-1_8  0.04
2015 Erdozain AM, Rubio M, Meana JJ, Fernández-Ruiz J, Callado LF. Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects. Journal of Psychopharmacology (Oxford, England). PMID 26253623 DOI: 10.1177/0269881115599388  0.04
2015 Ragusa G, Gómez-Cañas M, Morales P, Hurst DP, Deligia F, Pazos R, Pinna GA, Fernández-Ruiz J, Goya P, Reggio PH, Jagerovic N, García-Arencibia M, Murineddu G. Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonists. European Journal of Medicinal Chemistry. 101: 651-67. PMID 26209834 DOI: 10.1016/j.ejmech.2015.06.057  0.04
2015 Erdozain AM, Rubio M, Valdizan EM, Pazos A, Meana JJ, Fernández-Ruiz J, Alexander SP, Callado LF. The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects. Addiction Biology. 20: 773-83. PMID 25041461 DOI: 10.1111/adb.12160  0.04
2014 Ooms M, Rietjens R, Rangarajan JR, Vunckx K, Valdeolivas S, Maes F, Himmelreich U, Fernandez-Ruiz J, Bormans G, Van Laere K, Casteels C. Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice. Neurobiology of Aging. 35: 2858-69. PMID 25018107 DOI: 10.1016/j.neurobiolaging.2014.06.010  0.04
2014 Moreno E, Andradas C, Medrano M, Caffarel MM, Pérez-Gómez E, Blasco-Benito S, Gómez-Cañas M, Pazos MR, Irving AJ, Lluís C, Canela EI, Fernández-Ruiz J, Guzmán M, McCormick PJ, Sánchez C. Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling. The Journal of Biological Chemistry. 289: 21960-72. PMID 24942731 DOI: 10.1074/jbc.M114.561761  0.04
2014 Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. 55: 791-802. PMID 24854329 DOI: 10.1111/epi.12631  0.04
2014 Chiarlone A, Bellocchio L, Blázquez C, Resel E, Soria-Gómez E, Cannich A, Ferrero JJ, Sagredo O, Benito C, Romero J, Sánchez-Prieto J, Lutz B, Fernández-Ruiz J, Galve-Roperh I, Guzmán M. A restricted population of CB1 cannabinoid receptors with neuroprotective activity. Proceedings of the National Academy of Sciences of the United States of America. 111: 8257-62. PMID 24843137 DOI: 10.1073/pnas.1400988111  0.04
2013 Espejo-Porras F, Fernández-Ruiz J, Pertwee RG, Mechoulam R, García C. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors. Neuropharmacology. 75: 155-63. PMID 23924692 DOI: 10.1016/j.neuropharm.2013.07.024  0.04
2013 Pryce G, Cabranes A, Fernández-Ruiz J, Bisogno T, Di Marzo V, Long JZ, Cravatt BF, Giovannoni G, Baker D. Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1896-904. PMID 23625705 DOI: 10.1177/1352458513485982  0.04
2013 Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? British Journal of Clinical Pharmacology. 75: 323-33. PMID 22625422 DOI: 10.1111/j.1365-2125.2012.04341.x  0.04
2013 Szafrański PW, Dyduch K, Kosciolek T, Wróbel TP, Gómez-Cañas M, Gómez-Ruiz M, Fernandez-Ruiz J, Mlynarski J. Design and synthesis of novel cannabinoid ligands based on a 1,2,3-triazole scaffold Letters in Drug Design and Discovery. 10: 169-172.  0.04
2012 Granja AG, Carrillo-Salinas F, Pagani A, Gómez-Cañas M, Negri R, Navarrete C, Mecha M, Mestre L, Fiebich BL, Cantarero I, Calzado MA, Bellido ML, Fernandez-Ruiz J, Appendino G, Guaza C, et al. A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 1002-16. PMID 22971837 DOI: 10.1007/s11481-012-9399-3  0.04
2011 Rubio M, Villain H, Docagne F, Roussel BD, Ramos JA, Vivien D, Fernandez-Ruiz J, Ali C. Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. Plos One. 6: e23690. PMID 21886913 DOI: 10.1371/journal.pone.0023690  0.04
2011 Fernández-Ruiz J, Moreno-Martet M, Rodríguez-Cueto C, Palomo-Garo C, Gómez-Cañas M, Valdeolivas S, Guaza C, Romero J, Guzmán M, Mechoulam R, Ramos JA. Prospects for cannabinoid therapies in basal ganglia disorders. British Journal of Pharmacology. 163: 1365-78. PMID 21545415 DOI: 10.1111/j.1476-5381.2011.01365.x  0.04
2011 Jazwa A, Rojo AI, Innamorato NG, Hesse M, Fernández-Ruiz J, Cuadrado A. Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxidants & Redox Signaling. 14: 2347-60. PMID 21254817 DOI: 10.1089/ars.2010.3731  0.04
2011 Blázquez C, Chiarlone A, Sagredo O, Aguado T, Pazos MR, Resel E, Palazuelos J, Julien B, Salazar M, Börner C, Benito C, Carrasco C, Diez-Zaera M, Paoletti P, Díaz-Hernández M, et al. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease. Brain : a Journal of Neurology. 134: 119-36. PMID 20929960 DOI: 10.1093/brain/awq278  0.04
2010 Kurz A, Double KL, Lastres-Becker I, Tozzi A, Tantucci M, Bockhart V, Bonin M, García-Arencibia M, Nuber S, Schlaudraff F, Liss B, Fernández-Ruiz J, Gerlach M, Wüllner U, Lüddens H, et al. A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. Plos One. 5: e11464. PMID 20628651 DOI: 10.1371/journal.pone.0011464  0.04
2010 Fernández-Ruiz J, Hernández M, Ramos JA. Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. Cns Neuroscience & Therapeutics. 16: e72-91. PMID 20406253 DOI: 10.1111/j.1755-5949.2010.00144.x  0.04
2010 Sagar DR, Jhaveri MD, Richardson D, Gray RA, de Lago E, Fernández-Ruiz J, Barrett DA, Kendall DA, Chapman V. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. The European Journal of Neuroscience. 31: 1414-22. PMID 20384778 DOI: 10.1111/j.1460-9568.2010.07162.x  0.04
2009 García-Arencibia M, García C, Kurz A, Rodríguez-Navarro JA, Gispert-Sáchez S, Mena MA, Auburger G, de Yébenes JG, Fernández-Ruiz J. Cannabinoid CB1 receptors are early downregulated followed by a further upregulation in the basal ganglia of mice with deletion of specific park genes. Journal of Neural Transmission. Supplementum. 269-75. PMID 20411785 DOI: 10.1007/978-3-211-92660-4-22  0.04
2009 Palazuelos J, Aguado T, Pazos MR, Julien B, Carrasco C, Resel E, Sagredo O, Benito C, Romero J, Azcoitia I, Fernández-Ruiz J, Guzmán M, Galve-Roperh I. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. Brain : a Journal of Neurology. 132: 3152-64. PMID 19805493 DOI: 10.1093/brain/awp239  0.04
2009 Gispert S, Ricciardi F, Kurz A, Azizov M, Hoepken HH, Becker D, Voos W, Leuner K, Müller WE, Kudin AP, Kunz WS, Zimmermann A, Roeper J, Wenzel D, Jendrach M, et al. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. Plos One. 4: e5777. PMID 19492057 DOI: 10.1371/journal.pone.0005777  0.04
2009 Sagredo O, González S, Aroyo I, Pazos MR, Benito C, Lastres-Becker I, Romero JP, Tolón RM, Mechoulam R, Brouillet E, Romero J, Fernández-Ruiz J. Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. Glia. 57: 1154-67. PMID 19115380 DOI: 10.1002/glia.20838  0.04
2008 Pazos MR, Sagredo O, Fernández-Ruiz J. The endocannabinoid system in Huntington's disease. Current Pharmaceutical Design. 14: 2317-25. PMID 18781982 DOI: 10.2174/138161208785740108  0.04
2007 Fernández-Ruiz J, Guzmán M, Ramos JA. Preface: cannabinoids as new tools for the treatment of neurological disorders. Molecular Neurobiology. 36: 1-2. PMID 17952644 DOI: 10.1007/s12035-007-8005-9  0.04
2007 Sagredo O, Ramos JA, Decio A, Mechoulam R, Fernández-Ruiz J. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors. The European Journal of Neuroscience. 26: 843-51. PMID 17672854 DOI: 10.1111/j.1460-9568.2007.05717.x  0.04
2007 Rubio M, McHugh D, Fernández-Ruiz J, Bradshaw H, Walker JM. Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. Neuroscience Letters. 421: 270-4. PMID 17574742 DOI: 10.1016/j.neulet.2007.05.052  0.04
2007 García-Arencibia M, González S, de Lago E, Ramos JA, Mechoulam R, Fernández-Ruiz J. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Research. 1134: 162-70. PMID 17196181 DOI: 10.1016/j.brainres.2006.11.063  0.04
2006 Rojo AI, Montero C, Salazar M, Close RM, Fernández-Ruiz J, Sánchez-González MA, de Sagarra MR, Jackson-Lewis V, Cavada C, Cuadrado A. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice. The European Journal of Neuroscience. 24: 1874-84. PMID 17067291 DOI: 10.1111/j.1460-9568.2006.05060.x  0.04
2005 de Lago E, Petrosino S, Valenti M, Morera E, Ortega-Gutierrez S, Fernandez-Ruiz J, Di Marzo V. Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels. Biochemical Pharmacology. 70: 446-52. PMID 15963472 DOI: 10.1016/j.bcp.2005.05.011  0.04
2005 González S, Mena MA, Lastres-Becker I, Serrano A, de Yébenes JG, Ramos JA, Fernández-Ruiz J. Cannabinoid CB(1) receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice. Brain Research. 1046: 195-206. PMID 15882845 DOI: 10.1016/j.brainres.2005.04.010  0.04
2005 Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fernández-Ruiz J. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. Neurobiology of Disease. 19: 96-107. PMID 15837565 DOI: 10.1016/j.nbd.2004.11.009  0.04
2005 Fernandez-Ruiz J. Pharmacology, Biochemistry and Behavior: Editorial Pharmacology Biochemistry and Behavior. 81: 221-223. DOI: 10.1016/j.pbb.2005.03.021  0.04
2004 Lastres-Becker I, Bizat N, Boyer F, Hantraye P, Fernández-Ruiz J, Brouillet E. Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo. Neuroreport. 15: 2375-9. PMID 15640759 DOI: 10.1097/00001756-200410250-00015  0.04
2004 de Lago E, Ligresti A, Ortar G, Morera E, Cabranes A, Pryce G, Bifulco M, Baker D, Fernandez-Ruiz J, Di Marzo V. In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. European Journal of Pharmacology. 484: 249-57. PMID 14744610 DOI: 10.1016/j.ejphar.2003.11.027  0.04
2003 Lastres-Becker I, Bizat N, Boyer F, Hantraye P, Brouillet E, Fernández-Ruiz J. Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate. Neuroreport. 14: 813-6. PMID 12858038 DOI: 10.1097/01.wnr.0000067781.69995.1b  0.04
2002 Wenger T, Gerendai I, Fezza F, González S, Bisogno T, Fernandez-Ruiz J, Di Marzo V. The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats. Life Sciences. 70: 1407-14. PMID 11883716 DOI: 10.1016/S0024-3205(01)01516-8  0.04
2002 Lastres-Becker I, Berrendero F, Lucas JJ, Martín-Aparicio E, Yamamoto A, Ramos JA, Fernández-Ruiz JJ. Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease. Brain Research. 929: 236-42. PMID 11864629 DOI: 10.1016/S0006-8993(01)03403-5  0.04
2001 Lastres-Becker I, Cebeira M, de Ceballos ML, Zeng BY, Jenner P, Ramos JA, Fernández-Ruiz JJ. Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets. The European Journal of Neuroscience. 14: 1827-32. PMID 11860478 DOI: 10.1046/j.0953-816X.2001.01812.x  0.04
2001 Niederhoffer N, Hansen HH, Fernandez-Ruiz JJ, Szabo B. Effects of cannabinoids on adrenaline release from adrenal medullary cells. British Journal of Pharmacology. 134: 1319-27. PMID 11704653 DOI: 10.1038/sj.bjp.0704359  0.04
2000 González S, Bisogno T, Wenger T, Manzanares J, Milone A, Berrendero F, Di Marzo V, Ramos JA, Fernández-Ruiz JJ. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochemical and Biophysical Research Communications. 270: 260-6. PMID 10733937 DOI: 10.1006/bbrc.2000.2406  0.04
2000 Sañudo-Peña MC, Romero J, Seale GE, Fernandez-Ruiz JJ, Walker JM. Activational role of cannabinoids on movement. European Journal of Pharmacology. 391: 269-74. PMID 10729368 DOI: 10.1016/S0014-2999(00)00044-3  0.04
2000 Fernández-Ruiz J, Berrendero F, Hernández ML, Ramos JA. The endogenous cannabinoid system and brain development. Trends in Neurosciences. 23: 14-20. PMID 10631784 DOI: 10.1016/S0166-2236(99)01491-5  0.04
1999 Fernández-Ruiz JJ, Berrendero F, Hernández ML, Romero J, Ramos JA. Role of endocannabinoids in brain development. Life Sciences. 65: 725-36. PMID 10462073  0.01
1999 González S, Manzanares J, Berrendero F, Wenger T, Corchero J, Bisogno T, Romero J, Fuentes JA, Di Marzo V, Ramos JA, Fernández-Ruiz J. Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland. Neuroendocrinology. 70: 137-45. PMID 10461028 DOI: 10.1159/000054468  0.04
1999 Corchero J, Romero J, Berrendero F, Fernandez-Ruiz J, Ramos JA, Fuentes JA, Manzanares J. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen. Brain Research. Molecular Brain Research. 67: 148-57. PMID 10101241 DOI: 10.1016/S0169-328X(99)00053-4  0.04
1998 Romero J, Berrendero F, García-Gil L, Ramos JA, Fernández-Ruiz JJ. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol. Journal of Molecular Neuroscience : Mn. 11: 109-19. PMID 10096037 DOI: 10.1385/JMN:11:2:109  0.01
1998 Romero J, Wenger T, de Miguel R, Ramos JA, Fernández-Ruiz JJ. Cannabinoid receptor binding did not vary in several hypothalamic nuclei after hypothalamic deafferentation. Life Sciences. 63: 351-6. PMID 9714422 DOI: 10.1016/S0024-3205(98)00283-5  0.04
1998 Romero J, de Miguel R, Ramos JA, Fernández-Ruiz JJ. The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake. Life Sciences. 62: 351-63. PMID 9450507  0.01
1997 Romero J, Garcia-Palomero E, Castro JG, Garcia-Gil L, Ramos JA, Fernandez-Ruiz JJ. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Brain Research. Molecular Brain Research. 46: 100-8. PMID 9191083  0.01
1996 Romero J, García-Palomero E, Fernández-Ruiz JJ, Ramos JA. Involvement of GABA(B) receptors in the motor inhibition produced by agonists of brain cannabinoid receptors. Behavioural Pharmacology. 7: 299-302. PMID 11224422  0.01
1995 Martín AI, Fernández-Ruiz J, López-Calderón A. Effects of catecholamine synthesis inhibitors and adrenergic receptor antagonists on restraint-induced LH release. The Journal of Endocrinology. 144: 511-5. PMID 7738475  0.04
1994 Hernández ML, Fernández-Ruiz JJ, Navarro M, de Miguel R, Cebeira M, Vaticón L, Ramos JA. Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin. Journal of Neural Transmission. General Section. 96: 63-79. PMID 7857592  0.01
1994 Bonnin A, Fernandez-Ruiz JJ, Cebeira M, Ramos JA. Effects of δ9-tetrahydrocannabinol on tuberoinfundibular dopaminergic activity and prolactin release in estrogen-replaced ovariectomized rats Neuroendocrinology Letters. 16: 305-314.  0.04
1992 Fernandez-Ruiz J, De Miguel R, Hernandez ML, Cebeira M, Ramos JA. Comparisons between brain dopaminergic neurons of juvenile and aged rats: sex-related differences. Mechanisms of Ageing and Development. 63: 45-55. PMID 1351122 DOI: 10.1016/0047-6374(92)90015-6  0.04
1992 Navarro M, Fernández-Ruiz JJ, Rodriguez de Fonseca F, Hernández ML, Cebeira M, Ramos JA. Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice. Pharmacology, Biochemistry, and Behavior. 43: 603-8. PMID 1332081 DOI: 10.1016/0091-3057(92)90197-N  0.04
1991 Cebeira M, Hernandez ML, Rodriguez de Fonseca F, de Miguel R, Fernandez-Ruiz JJ, Ramos JA. Lack of effect of prolactin on the dopaminergic receptor sensitivity in striatal and limbic areas after experimentally-induced alterations in its peripheral levels. Life Sciences. 48: 531-41. PMID 1671524 DOI: 10.1016/0024-3205(91)90468-Q  0.04
1990 Esquifino AI, Steger RW, Fernandez-Ruiz J, Bartkes A, Amador AG, Chandrashekar V. Effects of estrogen and ectopic pituitary transplants on the responsiveness of pituitary prolactin release to luteinizing hormone-releasing hormone and dopamine. Journal of Neuroendocrinology. 2: 145-9. PMID 19210377 DOI: 10.1111/j.1365-2826.1990.tb00844.x  0.04
1990 Rodriguez de Fonseca F, Cebeira M, Hernández ML, Ramos JA, Fernández-Ruiz JJ. Changes in brain dopaminergic indices induced by perinatal exposure to cannabinoids in rats. Brain Research. Developmental Brain Research. 51: 237-40. PMID 2138936 DOI: 10.1016/0165-3806(90)90280-C  0.04
1990 Fernandez-Ruiz JJ, Cebeira M, Rodriguez F, Ramos JA. Effects of dopamine on prolactin release from ectopic and hyperplastic anterior pituitaries: Changes at receptor and postreceptor level Neuroendocrinology Letters. 12: 455-463.  0.04
1989 Steger RW, Esquifino AI, Fernandez-Ruiz JJ, Bartke A. Prolonged neuroendocrine effects of a brief exposure of adult male rats to diethylstilbestrol. Neuroendocrinology. 49: 191-6. PMID 2725837 DOI: 10.1159/000125113  0.04
1989 de Miguel R, Fernández-Ruiz JJ, Hernández ML, Ramos JA. Role of ovarian steroids on the catecholamine synthesis and release in female rat adrenal: in vivo and in vitro studies. Life Sciences. 44: 1979-86. PMID 2567956  0.01
1989 Fernández-Ruiz JJ, Alvarez-Sanz C, Ramos JA. 2-Hydroxyestradiol is not mediating the effects of estradiol on tuberoinfundibular dopaminergic neurons controlling prolactin secretion in female rats. Journal of Steroid Biochemistry. 32: 71-5. PMID 2536446 DOI: 10.1016/0022-4731(89)90016-2  0.04
1989 Fernández-Ruiz JJ, Amor JC, Ramos JA. Time-dependent effects of estradiol and progesterone on the number of striatal dopaminergic D2-receptors. Brain Research. 476: 388-95. PMID 2522808 DOI: 10.1016/0006-8993(89)91266-3  0.04
1988 Fernández-Ruiz JJ, Agrasal C, Cebeira M, Tresguerres JA, Esquifino AI, Ramos JA. Effects of estradiol on circulating levels of prolactin in female rats bearing ectopic pituitaries. Revista EspañOla De FisiologíA. 44: 205-10. PMID 3194578  0.01
1987 Fernandez-Ruiz J, Cebeira M, Agrasal C, Tresguerres JA, Esquifino AI, Ramos JA. Effect of elevated prolactin levels on the synthesis and release of catecholamines from the adrenal medulla in female rats. Neuroendocrinology. 45: 208-11. PMID 3561696  0.04
1987 Ramos JA, Pais JR, Cebeira M, Fernandez-Ruiz J. Role of estrogens on striatal dopaminergic activity. Journal of Steroid Biochemistry. 27: 683-9. PMID 2961941 DOI: 10.1016/0022-4731(87)90137-3  0.04
1987 Fernandez-Ruiz JJ, Agrasal C, Steger RW. Involvement of endogenous catecholamines in the control of prolactin secretion from ectopic pituitary transplants in hypophysectomized female rats Neuroendocrinology Letters. 9: 237-247.  0.04
2019 Romo-García MF, Bastian Y, Zapata-Zuñiga M, Macías-Segura N, Castillo-Ortiz JD, Lara-Ramírez EE, Fernández-Ruiz JC, Berlanga-Taylor AJ, González-Amaro R, Ramos-Remus C, Enciso-Moreno JA, Castañeda-Delgado JE. Identification of putative miRNA biomarkers in early rheumatoid arthritis by genome-wide microarray profiling: A pilot study. Gene. 720: 144081. PMID 31473322 DOI: 10.1016/j.gene.2019.144081  0.01
2016 Reginold W, Luedke AC, Itorralba J, Fernandez-Ruiz J, Islam O, Garcia A. Altered Superficial White Matter on Tractography MRI in Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders Extra. 6: 233-41. PMID 27489557 DOI: 10.1159/000446770  0.01
2015 Reginold W, Luedke AC, Tam A, Itorralba J, Fernandez-Ruiz J, Reginold J, Islam O, Garcia A. Cognitive Function and 3-Tesla Magnetic Resonance Imaging Tractography of White Matter Hyperintensities in Elderly Persons. Dementia and Geriatric Cognitive Disorders Extra. 5: 387-394. PMID 26628897 DOI: 10.1159/000439045  0.01
2015 Moreno-Martet M, Feliú A, Espejo-Porras F, Mecha M, Carrillo-Salinas FJ, Fernández-Ruiz J, Guaza C, de Lago E. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ(9)-tetrahydrocannabinol acting through CB1 receptors. Multiple Sclerosis and Related Disorders. 4: 505-11. PMID 26590655 DOI: 10.1016/j.msard.2015.08.001  0.01
2015 Fernández-Ruiz J, Moro MA, Martínez-Orgado J. Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 793-806. PMID 26260390 DOI: 10.1007/s13311-015-0381-7  0.01
2015 García C, Palomo-Garo C, Gómez-Gálvez Y, Fernández-Ruiz J. Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia. British Journal of Pharmacology. PMID 26059564 DOI: 10.1111/bph.13215  0.01
2015 Fernández Ruiz JS. [Where are we?]. Semergen / Sociedad EspañOla De Medicina Rural Y Generalista. 41: 61-2. PMID 25742775 DOI: 10.1016/j.semerg.2015.02.001  0.01
2013 Fernández Ruiz JS. [Objective: impact factor]. Semergen / Sociedad EspañOla De Medicina Rural Y Generalista. 39: 181-2. PMID 23726728 DOI: 10.1016/j.semerg.2013.04.004  0.01
2013 Casarejos MJ, Perucho J, Gomez A, Muñoz MP, Fernandez-Estevez M, Sagredo O, Fernandez Ruiz J, Guzman M, de Yebenes JG, Mena MA. Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy. Journal of Alzheimer's Disease : Jad. 35: 525-39. PMID 23478312 DOI: 10.3233/JAD-130050  0.01
2013 Fernández-Fernández C, Decara J, Bermúdez-Silva FJ, Sánchez E, Morales P, Gómez-Cañas M, Gómez-Ruíz M, Callado LF, Goya P, Rodríguez de Fonseca F, Martín MI, Fernández-Ruíz J, Meana JJ, Jagerovic N. Description of a bivalent cannabinoid ligand with hypophagic properties. Archiv Der Pharmazie. 346: 171-9. PMID 23371794 DOI: 10.1002/ardp.201200392  0.01
2012 Fernández Ruiz JS. [Socio-sanitary integration: new challenge for primary care]. Semergen / Sociedad EspañOla De Medicina Rural Y Generalista. 38: 1-2. PMID 24847532  0.01
2012 Fernández Ruiz JS. [SEMERGEN XXXIV National Conference - the chronic patient: our responsibility]. Semergen / Sociedad EspañOla De Medicina Rural Y Generalista. 38: 201-2. PMID 23544719 DOI: 10.1016/j.semerg.2012.04.012  0.01
2012 Fernández-Ruiz J. [Cannabinoid drugs for neurological diseases: what is behind?]. Revista De Neurologia. 54: 613-28. PMID 22573509  0.12
2009 Fernández-Ruiz J. The endocannabinoid system as a target for the treatment of motor dysfunction. British Journal of Pharmacology. 156: 1029-40. PMID 19220290 DOI: 10.1111/j.1476-5381.2008.00088.x  0.12
2008 Pazos MR, Tolón RM, Benito C, Rodríguez CF, Gorgojo JJ, Nevado M, Alvarez M, Arias F, Almodóvar F, Fernández MT, Lledó JL, González S, Fernández-Ruiz JJ, Romero J. Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 56: 511-6. PMID 18285348 DOI: 10.1369/jhc.2008.950741  0.01
2004 Suárez I, Bodega G, Rubio M, Fernández-Ruiz JJ, Ramos JA, Fernández B. Prenatal cannabinoid exposure down- regulates glutamate transporter expressions (GLAST and EAAC1) in the rat cerebellum. Developmental Neuroscience. 26: 45-53. PMID 15509898 DOI: 10.1159/000080711  0.01
2003 Lastres-Becker I, De Miguel R, Fernández-Ruiz JJ. The endocannabinoid system and Huntington's disease. Current Drug Targets. Cns and Neurological Disorders. 2: 335-47. PMID 14529364  0.01
2002 Suárez I, Bodega G, Fernández-Ruiz JJ, Ramos JA, Rubio M, Fernández B. Reduced glial fibrillary acidic protein and glutamine synthetase expression in astrocytes and Bergmann glial cells in the rat cerebellum caused by delta(9)-tetrahydrocannabinol administration during development. Developmental Neuroscience. 24: 300-12. PMID 12457068  0.01
2002 Gonzalez S, Fernandez-Ruiz J, Sparpaglione V, Parolaro D, Ramos JA. Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. Drug and Alcohol Dependence. 66: 77-84. PMID 11850139  0.01
2001 Hansen HH, Schmid PC, Bittigau P, Lastres-Becker I, Berrendero F, Manzanares J, Ikonomidou C, Schmid HH, Fernández-Ruiz JJ, Hansen HS. Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. Journal of Neurochemistry. 78: 1415-27. PMID 11579150  0.01
2001 Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, Davis JB, Fernandez-Ruiz JJ. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. European Journal of Pharmacology. 420: 123-31. PMID 11408034  0.01
2000 Gomes-da-Silva J, Perez-Rosado A, de Miguel R, Fernandez-Ruiz J, Silva MC, Tavares MA. Neonatal methamphetamine in the rat: evidence for gender-specific differences upon tyrosine hydroxylase enzyme in the dopaminergic nigrostriatal system. Annals of the New York Academy of Sciences. 914: 431-8. PMID 11085342  0.01
2000 Suárez I, Bodega G, Ramos JA, Fernández-Ruiz JJ, Fernández B. Neuronal and astroglial response to pre- and perinatal exposure to delta-9-tetra- hydrocannabinol in the rat substantia nigra. Developmental Neuroscience. 22: 253-63. PMID 10965147  0.01
2000 Romero J, Berrendero F, Pérez-Rosado A, Manzanares J, Rojo A, Fernández-Ruiz JJ, de Yebenes JG, Ramos JA. Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen. Life Sciences. 66: 485-94. PMID 10794065  0.01
2000 Di Marzo V, Berrendero F, Bisogno T, González S, Cavaliere P, Romero J, Cebeira M, Ramos JA, Fernández-Ruiz JJ. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats. Journal of Neurochemistry. 74: 1627-35. PMID 10737621  0.01
2000 Fernandez-Ruiz J. Debt buybacks, debt reduction, and debt rescheduling under asymmetric information Journal of Money, Credit and Banking. 32: 13-27.  0.01
1999 Wenger T, Fernández-Ruiz JJ, Ramos JA. Immunocytochemical demonstration of CB1 cannabinoid receptors in the anterior lobe of the pituitary gland. Journal of Neuroendocrinology. 11: 873-8. PMID 10520138 DOI: 10.1046/j.1365-2826.1999.00402.x  0.01
1999 González S, Romero J, de Miguel R, Lastres-Becker I, Villanua MA, Makriyannis A, Ramos JA, Fernández-Ruiz JJ. Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide. Life Sciences. 65: 327-36. PMID 10447218  0.01
1999 Berrendero F, Sepe N, Ramos JA, Di Marzo V, Fernández-Ruiz JJ. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse (New York, N.Y.). 33: 181-91. PMID 10420166 DOI: 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R  0.01
1999 Romero J, Berrendero F, García-Gil L, Lin SY, Makriyannis A, Ramos JA, Fernández-Ruiz JJ. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide. Neurochemistry International. 34: 473-82. PMID 10402222  0.01
1999 García-Gil L, Romero J, Ramos JA, Fernández-Ruiz JJ. Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to delta9-tetrahydrocannabinol. Drug and Alcohol Dependence. 55: 127-36. PMID 10402157  0.01
1999 Manzanares J, Corchero J, Romero J, Fernández-Ruiz JJ, Ramos JA, Fuentes JA. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends in Pharmacological Sciences. 20: 287-94. PMID 10390647  0.01
1999 Garcia-Gil L, de Miguel R, Romero J, Perez A, Ramos JA, Fernández-Ruiz JJ. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats. Neurotoxicology and Teratology. 21: 277-83. PMID 10386831  0.01
1999 Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernandez-Ruiz JJ, Di Marzo V. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochemical and Biophysical Research Communications. 256: 377-80. PMID 10079192 DOI: 10.1006/bbrc.1999.0254  0.01
1998 de Miguel R, Romero J, Muñoz RM, García-Gil L, González S, Villanua MA, Makriyannis A, Ramos JA, Fernández-Ruiz JJ. Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs. Biochemical Pharmacology. 56: 1331-8. PMID 9825732  0.01
1998 Trujillo Santos A, Fernández Ruiz JL. [Pulmonary nodules with cavitation and bilateral pleural effusion]. Revista ClíNica EspañOla. 198: 623-4. PMID 9803786  0.01
1998 Romero J, Berrendero F, Manzanares J, Pérez A, Corchero J, Fuentes JA, Fernández-Ruiz JJ, Ramos JA. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol. Synapse (New York, N.Y.). 30: 298-308. PMID 9776133 DOI: 10.1002/(SICI)1098-2396(199811)30:3<298::AID-SYN7>3.0.CO;2-6  0.01
1998 García-Gil L, Ramos JA, Rubino T, Parolaro D, Fernández-Ruiz JJ. Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats. Neurotoxicology and Teratology. 20: 549-53. PMID 9761594  0.01
1998 Vela G, Martín S, García-Gil L, Crespo JA, Ruiz-Gayo M, Fernández-Ruiz JJ, García-Lecumberri C, Pélaprat D, Fuentes JA, Ramos JA, Ambrosio E. Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats. Brain Research. 807: 101-9. PMID 9757010  0.01
1998 Berrendero F, Romero J, García-Gil L, Suarez I, De la Cruz P, Ramos JA, Fernández-Ruiz JJ. Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats. Biochimica Et Biophysica Acta. 1407: 205-14. PMID 9748581  0.01
1998 Corchero J, García-Gil L, Manzanares J, Fernández-Ruiz JJ, Fuentes JA, Ramos JA. Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats. Life Sciences. 63: 843-50. PMID 9734704  0.01
1998 Berrendero F, García-Gil L, Hernández ML, Romero J, Cebeira M, de Miguel R, Ramos JA, Fernández-Ruiz JJ. Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development (Cambridge, England). 125: 3179-88. PMID 9671590  0.01
1998 Romero J, Fernández-Ruiz JJ, Vela G, Ruiz-Gayo M, Fuentes JA, Ramos JA. Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice. Drug and Alcohol Dependence. 50: 241-9. PMID 9649978  0.01
1998 Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA. Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain. Brain Research. Molecular Brain Research. 55: 126-32. PMID 9645967  0.01
1998 Romero J, Berrendero F, Garcia-Gil L, de la Cruz P, Ramos JA, Fernández-Ruiz JJ. Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience. 84: 1075-83. PMID 9578396  0.01
1997 García-Gil L, De Miguel R, Muñoz RM, Cebeira M, Villanua MA, Ramos JA, Fernández-Ruiz JJ. Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats. Neurotoxicology and Teratology. 19: 477-87. PMID 9392783  0.01
1997 Fernández-Ruiz JJ, Muñoz RM, Romero J, Villanua MA, Makriyannis A, Ramos JA. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics. Biochemical Pharmacology. 53: 1919-27. PMID 9256167 DOI: 10.1016/S0006-2952(97)00168-8  0.01
1997 Hernández ML, García-Gil L, Berrendero F, Ramos JA, Fernández-Ruiz JJ. delta 9-Tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons. Journal of Molecular Neuroscience : Mn. 8: 83-91. PMID 9188039 DOI: 10.1007/BF02736775  0.01
1997 Romero J, Garcia-Palomero E, Berrendero F, Garcia-Gil L, Hernandez ML, Ramos JA, Fernández-Ruiz JJ. Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse (New York, N.Y.). 26: 317-23. PMID 9183820 DOI: 10.1002/(SICI)1098-2396(199707)26:3<317::AID-SYN12>3.0.CO;2-S  0.01
1996 Bonnin A, de Miguel R, Castro JG, Ramos JA, Fernandez-Ruiz JJ. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain. Journal of Molecular Neuroscience : Mn. 7: 291-308. PMID 8968950 DOI: 10.1007/BF02737066  0.01
1996 García L, de Miguel R, Ramos JA, Fernàndez-Ruiz JJ. Perinatal delta 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs. Drug and Alcohol Dependence. 42: 155-66. PMID 8912798  0.01
1996 Navarro M, de Miguel R, Rodríguez de Fonseca F, Ramos JA, Fernández-Ruiz JJ. Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats. Behavioural Brain Research. 75: 91-8. PMID 8800663  0.01
1996 Romero J, García-Palomero E, Lin SY, Ramos JA, Makriyannis A, Fernández-Ruiz JJ. Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand. Life Sciences. 58: 1249-57. PMID 8614278 DOI: 10.1016/0024-3205(96)00086-0  0.01
1996 Fernandez-Ruiz J. Debt and incentives in a dynamic context Journal of International Economics. 41: 139-151.  0.01
1995 Romero J, de Miguel R, García-Palomero E, Fernández-Ruiz JJ, Ramos JA. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. Brain Research. 694: 223-32. PMID 8974649  0.01
1995 Bonnin A, de Miguel R, Hernández ML, Ramos JA, Fernández-Ruiz JJ. The prenatal exposure to delta 9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development. Life Sciences. 56: 2177-84. PMID 7776847  0.01
1995 Romero J, García L, Cebeira M, Zadrozny D, Fernández-Ruiz JJ, Ramos JA. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. Life Sciences. 56: 2033-40. PMID 7776829  0.01
1995 Romero J, García L, Fernández-Ruiz JJ, Cebeira M, Ramos JA. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Pharmacology, Biochemistry, and Behavior. 51: 731-7. PMID 7675852  0.01
1995 Guzmán M, Fernández-Ruiz JJ, Sánchez C, Velasco G, Ramos JA. Effects of anandamide on hepatic fatty acid metabolism. Biochemical Pharmacology. 50: 885-8. PMID 7575652  0.01
1994 Rodríguez de Fonseca F, Cebeira M, Ramos JA, Martín M, Fernández-Ruiz JJ. Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sciences. 54: 159-70. PMID 8289577  0.01
1994 Rodríguez de Fonseca F, Gorriti MA, Fernández-Ruiz JJ, Palomo T, Ramos JA. Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacology, Biochemistry, and Behavior. 47: 33-40. PMID 8115426  0.01
1994 Bonnin A, de Miguel R, Fernández-Ruiz JJ, Cebeira M, Ramos JA. Possible role of the cytochrome P450-linked monooxygenase system in preventing delta 9-tetrahydrocannabinol-induced stimulation of tuberoinfundibular dopaminergic activity in female rats. Biochemical Pharmacology. 48: 1387-92. PMID 7945437  0.01
1994 Navarro M, Rodríguez de Fonseca F, Hernández ML, Ramos JA, Fernández-Ruiz JJ. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacology, Biochemistry, and Behavior. 47: 47-58. PMID 7906890  0.01
1994 Bonnin A, de Miguel R, Rodríguez-Manzaneque JC, Fernández-Ruiz JJ, Santos A, Ramos JA. Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoids. Brain Research. Developmental Brain Research. 81: 147-50. PMID 7805282  0.01
1993 Rodríguez de Fonseca F, Ramos JA, Bonnin A, Fernández-Ruiz JJ. Presence of cannabinoid binding sites in the brain from early postnatal ages. Neuroreport. 4: 135-8. PMID 8453049  0.01
1993 Navarro M, Fernández-Ruiz JJ, De Miguel R, Hernández ML, Cebeira M, Ramos JA. Motor disturbances induced by an acute dose of delta 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations. Pharmacology, Biochemistry, and Behavior. 45: 291-8. PMID 8392200  0.01
1993 Navarro M, Fernández-Ruiz JJ, de Miguel R, Hernández ML, Cebeira M, Ramos JA. An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity. Behavioural Brain Research. 57: 37-46. PMID 8292253  0.01
1993 Bonnin A, Fernández-Ruiz JJ, Martín M, Rodríguez de Fonseca F, Hernández ML, Ramos JA. delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens. Journal of Neural Transmission. General Section. 92: 81-95. PMID 8103663  0.01
1993 Bonnin A, Ramos JA, Rodríguez de Fonseca F, Cebeira M, Fernández-Ruiz JJ. Acute effects of delta 9-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle. Neuroendocrinology. 58: 280-6. PMID 7902959  0.01
1992 Rodríguez de Fonseca F, Hernández ML, de Miguel R, Fernández-Ruiz JJ, Ramos JA. Early changes in the development of dopaminergic neurotransmission after maternal exposure to cannabinoids. Pharmacology, Biochemistry, and Behavior. 41: 469-74. PMID 1350099  0.01
1992 Rodríguez De Fonseca F, Fernández-Ruiz JJ, Murphy LL, Cebeira M, Steger RW, Bartke A, Ramos JA. Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas. Pharmacology, Biochemistry, and Behavior. 42: 269-75. PMID 1321451  0.01
1991 Hernández ML, de Miguel R, Ramos JA, Fernández-Ruiz JJ. Is prolactin playing a role in the regulation of catecholamine synthesis and release from male rat adrenal medulla? Journal of Endocrinological Investigation. 14: 201-8. PMID 2071822 DOI: 10.1007/BF03346789  0.01
1991 Rodríguez de Fonseca F, Cebeira M, Fernández-Ruiz JJ, Navarro M, Ramos JA. Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience. 43: 713-23. PMID 1922791  0.01
1991 Rodríguez de Fonseca F, Fernández-Ruiz JJ, Murphy L, Eldridge JC, Steger RW, Bartke A. Effects of delta-9-tetrahydrocannabinol exposure on adrenal medullary function: evidence of an acute effect and development of tolerance in chronic treatments. Pharmacology, Biochemistry, and Behavior. 40: 593-8. PMID 1687229  0.01
1991 Fernández-Ruiz JJ, Hernández ML, de Miguel R, Ramos JA. Nigrostriatal and mesolimbic dopaminergic activities were modified throughout the ovarian cycle of female rats. Journal of Neural Transmission. General Section. 85: 223-9. PMID 1681824  0.01
1991 Hernández ML, Fernández-Ruiz JJ, de Miguel R, Ramos JA. Time-dependent effects of ovarian steroids on tyrosine hydroxylase activity in the limbic forebrain of female rats. Journal of Neural Transmission. General Section. 83: 77-84. PMID 1673346  0.01
1990 Fernández-Ruiz JJ, de Miguel R, Hernández ML, Ramos JA. Time-course of the effects of ovarian steroids on the activity of limbic and striatal dopaminergic neurons in female rat brain. Pharmacology, Biochemistry, and Behavior. 36: 603-6. PMID 2377660  0.01
1990 Hernández ML, de Miguel R, Ramos JA, Fernández-Ruiz JJ. Prolactin inhibits the activity of tyrosine hydroxylase in cultured bovine adrenal chromaffin cells in a dose-dependent manner. Brain Research. 528: 175-8. PMID 1978793  0.01
1989 Fernandez-Ruiz JJ, Bukhari AR, Hernandez ML, Alemany J, Ramos JA. Sex- and age-related changes in catecholamine metabolism and release of rat adrenal gland. Neurobiology of Aging. 10: 331-5. PMID 2812194  0.01
1989 Esquifino AI, Agrasal C, Steger RW, Fernandez-Ruiz JJ, Amador AG, Bartke A. Regulation of GH and TSH release from hyperplastic and ectopic pituitaries: effects of dopamine in vitro. Life Sciences. 45: 199-206. PMID 2761337 DOI: 10.1016/0024-3205(89)90251-8  0.01
1989 Fernandez-Ruiz JJ, Esquifino AI, Steger RW, Bukhari AR, Bartke A. Changes in the catecholamine metabolism in the adrenal medulla of male hamsters with experimental hyperprolactinemia. Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology. 93: 303-6. PMID 2572385 DOI: 10.1016/0742-8413(89)90237-5  0.01
1989 Amador AG, Esquifino AI, Bartke A, Chandrashekar V, Fernández-Ruiz JJ, Steger RW, Hodges SL. Effects of diethylstilboestrol on testicular function and luteinizing hormone receptors. Revista EspañOla De FisiologíA. 45: 245-53. PMID 2515561 DOI: 10.1016/j.molcel.2014.07.011  0.01
1988 Fernández-Ruiz JJ, Bukhari AR, Martínez-Arrieta R, Tresguerres JA, Ramos JA. Effects of estrogens and progesterone on the catecholaminergic activity of the adrenal medulla in female rats. Life Sciences. 42: 1019-28. PMID 3343893  0.01
1988 Fernandez-Ruiz JJ, Martinez-Arrieta R, Hernandez ML, Ramos JA. Possible direct effect of prolactin on catecholamine synthesis and release in rat adrenal medulla: in vitro studies. Journal of Endocrinological Investigation. 11: 603-8. PMID 3243966 DOI: 10.1007/BF03350190  0.01
1987 Fernández-Ruiz JJ, Cebeira M, Agrasal C, Tresguerres JA, Bartke A, Esquifino AI, Ramos JA. Possible role of dopamine and noradrenaline in the regulation of prolactin secretion from an ectopic anterior pituitary gland in female rats. The Journal of Endocrinology. 113: 45-9. PMID 3585225 DOI: 10.1677/joe.0.1130045  0.01
1987 Fernández-Ruiz JJ, Ubeda E, Cebeira M, Agrasal C, Tresguerres JA, Ramos JA, Esquifino AI. Modifications of plasma prolactin levels and catecholamine content in an ectopic anterior pituitary gland transplanted under the kidney capsule. Hormone Research. 25: 105-12. PMID 3570148  0.01
1987 Esquifino AI, Fernández-Ruiz JJ, Cebeira M, Agrasal C, Tresguerres JA, Ramos JA. Effect of experimentally induced hyperprolactinemia on growth hormone secretion. Revista EspañOla De FisiologíA. 43: 463-8. PMID 3448711  0.01
1987 Esquifino AI, Agrasal C, Steger R, Fernández-Ruiz JJ, Ramos JA, Cebeira M, Bartke A. Catecholaminergic control of plasma growth hormone and thyrotropin levels in hypophysectomized rats bearing ectopic pituitary transplants. Life Sciences. 41: 1043-50. PMID 3039277 DOI: 10.1016/0024-3205(87)90694-1  0.01
1987 Fernandez-Ruiz JJ, Esquifino AI, Steger RW, Amador AG, Bartke A. Presence of tyrosine-hydroxylase activity in anterior pituitary adenomas and ectopic anterior pituitaries in male rats. Brain Research. 421: 65-8. PMID 2891404  0.01
1979 Higuero Moreno F, Menéndez Rubio JM, Usea G, Fernandez Ruíz JE, de la Cruz Vigo F, de la Cruz Caro F. [Hemangioendothelioma of the cecum]. Revista EspañOla De Las Enfermedades Del Aparato Digestivo. 56: 251-6. PMID 523747  0.01
Hide low-probability matches.